Advances in scientific innovation are leading to powerful discoveries about Alzheimer’s and neurodegenerative diseases, sparking hope for the development of new treatment and therapies for the conditions.
The Tri-Institutional Therapeutics Discovery Institute is speeding early-stage drug development through an innovative collaboration between academia and industry.
